Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Thrombosis and Haemostasis|November 13, 2021
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive SummaryTze-Fan Chao, Boyoung Joung, Yoshihide Takahashi, et al.
The American Journal of Medicine|April 5, 2022
Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or ThrombocytopeniaYung-Hsin Yeh, Yi-Hsin Chan, Shao-Wei Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2024
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial FibrillationYi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, et al.
Biomedicines|December 23, 2022
Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking RivaroxabanTze-Fan Chao, Yi-Hsin Chan, Pei-Chien Tsai, et al.
Plos One|October 10, 2014
Relationship between lung function and metabolic syndromeWei-Liang Chen, Chung-Ching Wang, Li-Wei Wu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 9, 2018
Short-term heart rate variability as a predictor of long-term survival in patients with chronic hemodialysis: A prospective cohort studyGeorge Kuo, Szi-Wen Chen, Jeng-Yi Huang, et al.
Frontiers in Cardiovascular Medicine|March 21, 2024
Clinical significance of regional constructive and wasted work in patients receiving cardiac resynchronization therapyChun-Li Wang, Lung-Sheng Wu, Chia-Tung Wu, et al.
Journal of the American Heart Association|April 7, 2018
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial FibrillationYi-Hsin Chan, Lai-Chu See, Hui-Tzu Tu, et al.
Pageof 19